Law Firm Asks USPTO to Re-Examine Foundational Array Patent Held by Affy

The ex parte request follows two similar petitions the law firm filed on behalf of an undisclosed client in February to reexamine two foundational Oxford Gene Technology patents, and could be part an apparent effort to compel the agency to take another look at foundational microarray IP.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.